Cell-Based Therapies for Diabetic Complications

  • Stella Bernardi
    Department of Morphology and Embriology and LTTA Centre, University of Ferrara, 44100 Ferrara, Italy
  • Giovanni Maria Severini
    Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, 34137, Italy
  • Giorgio Zauli
    Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, 34137, Italy
  • Paola Secchiero
    Department of Morphology and Embriology and LTTA Centre, University of Ferrara, 44100 Ferrara, Italy

抄録

<jats:p>In recent years, accumulating experimental evidence supports the notion that diabetic patients may greatly benefit from cell-based therapies, which include the use of adult stem and/or progenitor cells. In particular, mesenchymal stem cells and the circulating pool of endothelial progenitor cells have so far been the most studied populations of cells proposed for the treatment of vascular complications affecting diabetic patients. We review the evidence supporting their use in this setting, the therapeutic benefits that these cells have shown so far as well as the challenges that cell-based therapies in diabetic complications put out.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ